Trial NCT03170115

View at ClinicalTrials.gov 
Org. Study IDs: ICAR trial

Last trial update was posted on 2020-12-17

MeSH Interventions

Aspirin

MeSH Conditions

Neoplasms Rectal Neoplasms

Other Conditions

Chemoradiation Locally Advanced Malignant Neoplasm Rectal Cancer, Adenocarcinoma

Stopping Reasons

Aspirin added to chemoradiotherapy was safe but did not improve response to total neoadjuvant treatment. The study was closed due absence of benefit.

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID